throbber

`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Dr. Neal Sondheimer
`Assistant Professor of Paediatrics
`
`A. Date Curriculum Vitae is Prepared: 2018-08-15
`
`B. Biographical Information
`
`PGCRL 12-9712
`The Hospital for Sick Children
`686 Bay Street
`Toronto, ON M5G 0A4
`416-813-7654 ext. 301480
`416-813-4940
`neal.sondheimer@sickkids.ca
`
`Primary Office
`
`Telephone
`Fax
`Email
`
`
`1. EDUCATION
`
`Degrees
`
`June 1995 - June 2002
`
`Doctor of Medicine (M.D.), University of Chicago, Pritzker School of Medicine, Chicago,
`Illinois, United States.
`
`June 1995 - Dec 2000
`
`Doctor of Philosophy (Ph.D.), Molecular Genetics and Cell Biology, University of Chicago,
`Chicago, Illinois, United States. Dissertation mentor: Lindquist, Susan
`Thesis Title: Identification of novel prion elements in Saccharomyces cerevisiae
`
`Sep 1990 - June 1994
`
`Bachelor of Arts (A.B.), Biology, Harvard University, Cambridge, Massachusetts, United
`States.
`
`Postgraduate, Research and Specialty Training
`July 2007 - June 2009
`Post-Doctoral Fellow, Genetics, Children’s Hospital of Philadelphia, Philadelphia,
`Pennsylvania, United States. Supervisor(s): Narayan Avadhani.
`
`July 2007 - June 2008
`
`Fellow in Clinical Biochemical Genetics, Children’s Hospital of Philadelphia, Philadelphia,
`Pennsylvania, United States.
`
`June 2002 - June 2007
`
`Resident in Paediatrics, Children’s Hospital of Philadelphia, Philadelphia, Pennsylvania,
`United States.
`
`June 2002 - June 2008
`
`Resident in Genetics, Children’s Hospital of Philadelphia, Philadelphia, Pennsylvania, United
`States.
`
`Qualifications, Certifications and Licenses
`2007 - Present
`Specialty Certification, American Academy of Pediatrics, Elk Grove Village, Illinois, United
`States.
`Specialty Certification - Clinical Genetics, American Board of Medical Genetics and
`Genomics, Bethesda, Maryland, United States.
`
`2007 - Present
`
`Par Pharmaceutical, Inc. Ex. 1003
`Par v. Horizon, IPR of Patent No. 9,561,197
`Page 1 of 15
`
`

`


`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`

`
`Neal Sondheimer
`
`2009 - Present
`
`2017 – Present
`
`2. EMPLOYMENT
`
`Current Appointments
`HOSPITAL
`Sept 2015 - Present
`
`Specialty Certification - Clinical Biochemical Genetics, American Board of Medical Genetics
`and Genomics, Bethesda, Maryland, United States.
`Canadian College of Medical Genetics, Affiliate Member
`
`Staff Physician, Clinical and Metabolic Genetics, The Hospital for Sick Children, Toronto,
`Ontario.
`
`Jan 2017 – Present
`
`Morbidity and Mortality Divisional Leader. Division of Clinical and Metabolic Genetics, The
`Hospital for Sick Children, Toronto, Ontario
`
`RESEARCH
`Sept 2015 - Present
`
`UNIVERSITY
`
`July 2018 - Present
`
`July 2018 - Present
`
`Associate Scientist, Genetics & Genome Biology, Research Institute, The Hospital for Sick
`Children, Toronto, Ontario.
`
`Member, Institute of Medical Sciences, University of Toronto, Toronto, Ontario.
`
`Associate Professor, Departments of Paediatrics and Molecular Genetics, University of
`Toronto, Toronto, Ontario.
`
`Previous Appointments
`
`HOSPITAL
`June 2014 - Aug 2015
`
`Training Director, Clinical Biochemical Genetics, Children's Hospital of Philadelphia,
`Philadelphia, Pennsylvania.
`
`June 2014 - Aug 2015
`
`Program Director, The Children’s Hospital of Philadelphia and Medical Genetics, University of
`Pennsylvania, Philadelphia, Pennsylvania.
`
`July 2013 - June2014
`
`Assistant Program Director, Genetics Residency Programs, Children's Hospital of
`Philadelphia, Philadelphia, Pennsylvania.
`
`Nov 2006 - Aug 2015
`
`Attending Physician, Biochemical Genetics, Children's Hospital of Philadelphia, Philadelphia,
`Pennsylvania.
`
`Jan 2017 – Aug 2017
`
`Interim Program Director, Postgraduate Medical Education, Department of Paediatrics,
`University of Toronto, Toronto, Ontario.
`
`RESEARCH
`Oct 2008 - June 2012
`
`UNIVERSITY
`
`Co-Director, Mitochondrial Research Affinity Group, Children's Hospital of Philadelphia,
`Philadelphia, Pennsylvania, United States.
`
`Sept 2015 – Jun 2018
`
`Assistant Professor, Department of Paediatrics, University of Toronto, Toronto, Ontario.
`
`
`
`Page 2 of 13
`
`Par Pharmaceutical, Inc. Ex. 1003
`Par v. Horizon, IPR of Patent No. 9,561,197
`Page 2 of 15
`
`

`


`
`Neal Sondheimer
`
`
`Sept 2016 – Jun 2018
`
`Jan 208 – June 2018
`
`June 2009 - Aug 2015
`
`
` July 2007 - June 2009
`
`
`
`June 2002 - June 2005
`
`Associate Member, Institue of Medical Sciences, The University of Toronto
`
`Assistant Professor, Molecular Genetics, The University of Toronto
`
`Assistant Professor of Pediatrics (Tenure track), Department of Paediatrics, Perelman School
`of Medicine, The University of Pennsylvania, Philadelphia, Pennsylvania
`
`Clinical Associate in Pediatrics, Department of Paediatrics, The University of Pennsylvania,
`Philadelphia,Pennsylvania..
`
`
`
`
`
`
`
`Instructor-B, Department of Paediatrics, The University of Pennsylvania, Philadelphia,
`Pennsylvania.
`

`
`Page 3 of 13
`
`Par Pharmaceutical, Inc. Ex. 1003
`Par v. Horizon, IPR of Patent No. 9,561,197
`Page 3 of 15
`
`

`


`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`

`
`Neal Sondheimer
`
`3. HONOURS AND CAREER AWARDS
`
`Distinctions and Research Awards
`INTERNATIONAL
`Received
`October 2016
`
`North American Metabolic Academy, Faculty.
`
`April 2013
`
`
`
`Young Physician-Scientist Award, American Society for Clinical Investigation, Ann
`Arbor, Michigan, United States.
`
`May 2012
`
`Society for Pediaric Research, The Woodlands, Texas, United States. Honorary Society.
`
`Teaching Awards
`LOCAL
`Received
`
`May 2016
`
`Margaret W. Thompson Award – Medical Genetics Education
`
`Professional Associations
`Member, Garrod Society
`Member, Society for the Study of Inborn Errors of Metabolism
`Member, Society for Inherited Metabolic Disorders
`Member, The Canadian College of Physicians and Surgeons of Ontario
`
`Apr 2017 – Present
`Sept 2016 - Present
`Sept 2016 - Present
`Aug 2015 - Present
`
`LOCAL
`Sept 2016 - Present
`
`Committee Member, STRAD Advisory Committee, Research Training Centre, The
`Hospital for Sick Children, Toronto, Ontario.
`
`Jan 2015 - Dec 2016
`
`Board Member, Research Ethics Board, Research Institute, The Hospital for Sick Children,
`Toronto, Ontario.
`
`Peer Review Activities
`EDITORIAL BOARDS
`July 2017 - Present
`
`Editorial Board, Molecular Case Studies, Cold Spring Harbor
`
`GRANT REVIEWS
`Reviewer. OGS 2017-2018 Scholarships
`
`Page 4 of 13
`
`Par Pharmaceutical, Inc. Ex. 1003
`Par v. Horizon, IPR of Patent No. 9,561,197
`Page 4 of 15
`
`

`


`
`
`
`
`
`
`
`
`
`
`
`
`

`
`Neal Sondheimer
`
`MANUSCRIPT REVIEWS
`Reviewer. Cold Spring Harbor Molecular Case Studies,Highwire
`Reviewer. American Journal of Obstetrics and Gynecology,Elsevier
`Reviewer. Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms, MGM,Elsevier
`Reviewer. Congenital Heart Disease, Wiley
`Reviewer. PLOS ONE, Public Library of Science
`Reviewer. Journal of Inherited Metabolic Disease
`Reviewer. Congenital Heart Disease
`Reviewer. npj: Genomic Medicine
`
`Other Research and Professional Activities
`Developer – MitoTIP – an algorithmic determination of mitochondrial tRNA mutation pathogenicity at
`www.mitomap.org
`
`Innovations and Development in Teaching and Education
`MGY470 Curriculum – Ethics in Clinical Genetics
`
`C. Academic History
`
`1. RESEARCH STATEMENTS
`
`My Research focuses on the regulation of mitochondrial gene expression and the impact of
`mitochondrial mutations in common and rare disease.
`▪ Strongly pathogenic mitochondrial mutations exist in a state of heteroplasmy, a mixture of normal and
`mutated genomes. This state provides opportunities for therapy, as the increase of wild type mitochondrial
`DNA or the suppression of mutated mitochondrial DNA could improve health. My team and I are
`investigating mechanisms that could allow shifts in heteroplasmic ratios.
`▪ Mitochondrial inheritance has the potential to impact high-prevalence phenotypes by its interactions with
`the mitochondrial genome. We are studying this question using common diseases and phenotypes such
`as Alzheimer disease, aging and preterm birth. In addition to mitonuclear coordination low prevalence
`heteroplasmic mutations in the mitochondrial DNA may have profound effects over time.
`▪ The mitochondrial genome is the small, densely coding, matrilineally inherited DNA that encodes core
`subunits of the electron transport chain. Many features of gene regulation are more similar to bacterial and
`phage systems than they are to gene regulation in the nucleus. Defects in the maintenance of
`mitochondrial DNA and in the translation of gene products are known causes of disease. Myself and my
`team are investigating the dysregulation of mitochondrial transcription as another possible avenue to
`bioenergetic failure.
`
`Page 5 of 13
`
`Par Pharmaceutical, Inc. Ex. 1003
`Par v. Horizon, IPR of Patent No. 9,561,197
`Page 5 of 15
`
`

`

`Neal Sondheimer
`
`2. RESEARCH AWARDS
`
`Grants, Contracts and Clinical Trials
`PEER-REVIEWED G R A N T S
`Funded
`May 2017-May 2018
`
`
`
`
`
`Nov 2014 - Dec 2019
`

`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`

`
`Principal Investigator. Mitochondrial variation, nuclear coordination and the risk for
`psychiatric illness. McLaughlin Accelerator Grant. $54,400.
`This grant seeks to investigate the role of low-level heteroplasmic variation in
`phenotypes such as bipolar disorder and schizophrenia.
`
`Co-Investigator. March of Dimes Center for Prematurity Research at the University of
`Pennsylvania. March of Dimes Foundation. $227,845 USD/yr [total project is $2M/yr].
`Operating Grant.
`The Transdisciplinary Research Center for Preterm Birth investigates metabolic and
`environmental cues leading to preterm birth. I lead the team responsible for examining the
`effect of somatic and inherited mitochondrial mutations upon the risk for preterm birth.)
`
`June 2016 - Aug 2016
`
`Principal Investigator. A pipeline for quantifying mitochondrial-nuclear misalignment and its
`effect on phenotypic variation. Starbucks Summer Studentship Research Program. The
`Hospital for Sick Children. $4,800.
`
`July 2014 - June 2015
`
`Dec 2012 - Aug 2015
`
`Sept 2012 - June 2015
`
`July 2013 - July 2014
`
`Sept 2012 - Aug 2014
`
`Principal Investigator. EGFR mutations in neonatal progeria. Foerderer Foundation.
`$45,000 USD/annual direct costs. Operating Grant
`Funding to support the evaluation of EGFR function in Roma patients with neonatal progeria
`syndromes.
`
`Co-Investigator. Regulation of erythropoiesis by the miR-144/451 microRNA locus. National
`Institutes of Health (NIH). R01DK092318. Principal Investigator: Weiss, Mitchell. $250,000
`USD/annual direct costs. Operating Grant
`Funding to support studies of the effect of microRNA in the development of hematopoiesis
`with a focus on the role of these miRNA in altering programs of mitochondriogenesis.
`
`Co-Investigator. Molecular and Epigenetic Mitochondriomics of Air Particles, Lead and
`Cognition. National Institutes of Health (NIH)/ National Institute of Environmental Health
`Sciences (NIEHS). R01ES021733. Principal Investigator: Baccarelli. Andrea. $53,215
`USD/annual direct costs. Operating Grant
`This subproject will investigate mitochondrial heteroplasmy and DNA damage in the
`MOBILIZE cohort as part of a larger study on the effects of pollution and aging upon
`cognition and epigenetic.
`
`Pilot Awardee. Skin Disease Research Center Pilot. National Institutes of Health (NIH).
`5P30AR057217-04. Principal Investigator: Stanley, John. $25,000 USD/annual direct costs.
`Operating Grant
`This award examines the role of somatically acquired mutations in the development and
`metastasis of squamous cell carcinoma.
`
`Principal Investigator. Alzheimer's Disease and the destabilization of the mitochondrial
`genome. Alzheimer's Association, New Investigator Research Grant. AANIRG-12-214360.
`$44,068 USD/annual direct costs. Operating Grant
`This award supports studies of region specific changes in mitochondrial DNA sequence and
`base modification in Alzheimer's disease.
`
`mitochondrial disorders for therapeutic use.
`
`Page 6 of 13
`
`Par Pharmaceutical, Inc. Ex. 1003
`Par v. Horizon, IPR of Patent No. 9,561,197
`Page 6 of 15
`
`

`


`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`

`
`Neal Sondheimer
`
`May 2009 - April 2014
`
`Submitted
`September 2017
`
`January 2018
`
`Principal Investigator. Mitochondrial Transcription and Pediatric Disease. National Institutes
`of Health (NIH)/The National Institute of Child. Health and Human Development. (NICHD).
`K08HD058022-01A1. $133,920 USD/annual direct costs. Operating Grant
`This career development award is in support of the primary investigator's efforts to establish
`his career as a physician scientist studying the effects of mitochondrial disease upon
`mitochondrial transcription.
`
`Principal Investigator. “Therapeutic Heteroplasmy Shift via G-Quadruplex Binding Agents” –
`CIHR – 4 years - $750,000
`
`Principal Investigator. “Transgenerational Mitochondrial Mutations in Autism” – SFARI – 1
`year $80,000USD
`
`Salary Support and Other Funding
`
`Principal Applicant. Research Institute Start-up Operating Funds. Research Institute, The
`Hospital for Sick Children. $450,000 CAD. Operating Grant.
`Start-up funds for operation of lab including personnel, supplies and service.
`
`Principal Applicant. Start-up Funds for Research. SickKids Centre for Genetic Medicine,
`The Hospital for Sick Children. $150 CAD. Operating Grant.
`Start-up funds for research.
`
`Recombinant prion-like proteins and materials comprising same. #7,569,660.
`
`OTHER FUNDING
`Sept 2015 - Aug 2018
`
`Aug 2015 - Mar 2018
`
`3. PATENTS
`
`Aug 2009
`
`D. Publications
`
`H index:
` Web of Science: 14
` Scopus: 14
`
`1. MOST SIGNIFICANT PUBLICATIONS
`
`Principal Author. Crawford,N., Prendergast,D., Oehlert,J.W., Shaw,G.M., Stevenson,D.K., Rappaport,N., Sirota,M.,
`Tishkoff,S.A. and Sondheimer,N. (2017) Divergent Patterns of Mitochondrial and Nuclear Ancestry Are Associated with
`the Risk for Preterm Birth. J. Pediatr., j.jpeds.2017.10.052 (epub ahead of print). Impact Factor: 3.874
`
`In this manuscript, we developed a test for the difference between mitochondrial and nuclear ancestries, which we named
`divergent ancestry. Divergent ancestry can be calculated based upon genome-wide SNP genotyping or whole exome or
`genome approaches. We demonstrated that high levels of divergent ancestry are associated with preterm birth and
`showed how this risk factor may explain excess risk for spontaneous preterm birth in African-Americans.
`
`Principal Author. Sonney,S., Leipzig,J., Lott,M.T., Zhang,S., Procaccio,V., Wallace,D.C. and Sondheimer,N. (2017)
`
`Page 7 of 13
`
`Par Pharmaceutical, Inc. Ex. 1003
`Par v. Horizon, IPR of Patent No. 9,561,197
`Page 7 of 15
`
`

`


`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Neal Sondheimer
`
`Predicting the pathogenicity of novel variants in mitochondrial tRNA with MitoTIP. PLoS Comput. Biol., 13, e1005867
`(epub ahead of print) Impact Factor: 4.542
`
`In this study, we took a bioinformatic approach to identifying the likelihood that any possible mitochondrial SNVs affecting
`tRNAs would cause disease. The tool will be valuable for both research and clinical studies, and is already used by
`diagnostic laboratories. The tool can be accessed using MITOMAP on line.
`
`Principal Author. Zollo O, Tiranti V, Sondheimer N. (2012). Transcriptional requirements of the distal heavy-strand
`promoter of mtDNA. Proceedings of the National Academy of Sciences of the United States of America. 109(17): 6508-12.
`Impact Factor: 9.674.
`
`Here, we showed conclusively that there are two transcriptional products emanating from the heavy-strand of the
`mitochondrial DNA. This divides the mRNA and rRNA synthesis roles and allows for differential regulation in response to
`environmental cues.
`
`Principal Author. Sondheimer N, Glatz CE, Tirone JE, Deardorff MA, Krieger AM, Hakonarson H. (2011). Neutral
`mitochondrial heteroplasmy and the influence of aging. Human Molecular Genetics. 20(8): 1653-9. Impact Factor: 6.393.
`
`In this study, working with SNP genotyping data, we showed that somatic mitochondrial mutagenesis acts as a clock,
`increasing over the course of age. This was the first study to demonstrate that the evaluation of heteroplasmy was
`possible using genotyping arrays.
`Principal Author. Sondheimer N, Lindquist S. (2000). Rnq1: an epigenetic modifier of protein function in yeast.
`Molecular Cell. 5(1): 163-72. Impact Factor: 14.714.
`
`In work in graduate school with Susan Lindquist, I identified the third known prion element of S. cerevisiae using a
`predictive approach based upon primary sequence. This paper has received >300 citations.
`
`2. OTHER PEER-REVIEWED PUBLICATIONS
`
`Journal Articles
`
`Principal Author. Kaufman, BA, Picard M, Sondheimer N., Mitochondrial DNA, Nuclear Context and the Risk for
`Carcinogenesis (2018). Environmental and Molecular Mutagenesis, doi: 10.1002/em.22169. (Epub ahead of print).
`Impact Factor: 3.575
`
`Co-Author. Hotz,M.J., Qing,D., Shashaty,M.G.S., Zhang,P., Faust,H., Sondheimer,N., Rivella,S., Worthen,G.S. and
`Mangalmurti,N.S. (2017) RBCs Homeostatically Bind mtDNA Through TLR9 to Maintain Quiescence and Prevent Lung
`Injury. Am. J. Respir. Crit. Care Med., 10.1164/rccm.201706-1161OC. Impact Factor: 13.204
`
`Principal Author. Zollo,O. and Sondheimer,N. (2017) Topological requirements of the mitochondrial heavy-strand
`promoters. Transcription, 5, 307–312. Impact Factor: (new journal)
`
`Co-Author. Lionel,A.C., Costain,G., Monfared,N., Walker,S., Reuter,M.S., Hosseini,S.M., Thiruvahindrapuram,B.,
`Merico,D., Jobling,R., Nalpathamkalam,T., et al. (2017) Improved diagnostic yield compared with targeted gene
`sequencing panels suggests a role for whole-genome sequencing as a first-tier genetic test. Genet. Med., 0, 1–9. (middle
`author) Impact Factor: 8.229
`
`Co-Author. Hogarth,K.A., Costford,S.R., Yoon,G., Sondheimer,N. and Maynes,J.T. (2017) DNM1L Variant Alters
`Baseline Mitochondrial Function and Response to Stress in a Patient with Severe Neurological Dysfunction. Biochem.
`Genet., 10.1007/s10528-017-9829-2 (epub ahead of print). Impact Factor: 1.543
`
`Principal Author. Neal Sondheimer, Stacy Hewson, Jessie M. Cameron, Gino R. Somers, Jane Dunning Broadbent,
`Catarina Maria Quinzii, and Ali B. Naini Novel recessive mutations in COQ4 cause severe infantile cardiomyopathy
`a n d encephalopathy associated with CoQ10 deficiency: A new case report and review of the literature. Accepted
`Molecular Genetics and Metabolism 2017. Impact Factor: 2.979
`
`Co-Author. Precision therapy for a new disorder of AMPA receptor recycling due to mutations in ATAD1.
`Ahrens-Nicklas RC, Umanah GK, Sondheimer N, Deardorff MA, Wilkens AB, Conlin LK, Santani AB, Nesbitt A, Juulsola
`J, Ma E, Dawson TM, Dawson VL, Marsh ED. Neurol Genet. 2017 Feb 1;3(1):e130
`
`Page 7 of 13
`
`Par Pharmaceutical, Inc. Ex. 1003
`Par v. Horizon, IPR of Patent No. 9,561,197
`Page 8 of 15
`
`

`


`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`

`
`Neal Sondheimer
`
`Co-Author. Assoum M, Philippe C, Isidor B, Perrin L, Makrythanasis P, Sondheimer N, Paris C, Douglas J, Lesca G,
`Antonarakis S, Hamamy H, Jouan T, Duffourd Y, Auvin S, Saunier A, Begtrup A, Nowak C, Chatron N, Ville
`D, Mireskandari K, Milani P, Jonveaux P, Lemeur G, Milh M, Amamoto M, Kato M, Nakashima M, Miyake
`N, Matsumoto N, Masri A, Thauvin-Robinet C, Rivière JB, Faivre L, Thevenon J. (2016). Autosomal-
`Recessive Mutations in AP3B2, Adaptor-Related Protein Complex 3 Beta 2 Subunit, Cause an Early-Onset
`Epileptic Encephalopathy with Optic Atrophy. The American Journal of Human Genetics. 99(6): 1368-1376. Impact Factor:
`10.794.
`
`Co-Author. Seifert EL, Gál A, Acoba MG, Li Q, Anderson-Pullinger L, Golenár T, Moffat C, Sondheimer N, Claypool
`SM, Hajnóczky G. (2016). Natural and induced mitochondrial phosphate carrier loss: differential dependence of
`mitochondrial metabolism and dynamics, and cell survival, on the extent of depletion. The Journal of Biological Chemistry.
`291(50): 26126-26137. Impact Factor: 4.258
`
`Collaborator. Seifert EL, Ligeti E, Mayr JA, Sondheimer N, Hajnóczky G. (2015). The mitochondrial phosphate carrier:
`Role in oxidative metabolism, calcium handling and mitochondrial disease. Biochemical and Biophysical Research
`Communications. 464(2): 369-75. Impact Factor: 2.297.
`
`Principal Author. Ganetzky R, Finn E, Bagchi A, Zollo O, Conlin L, Deardorff M, Harr M, Simpson MA, McGrath JA,
`Zackai E, Lemmon MA, Sondheimer N. (2015). EGFR mutations cause a lethal syndrome of epithelial dysfunction with
`progeroid features. Molecular Genetics & Genomic Medicine 2015. 3(5): 452-458. Impact Factor: No impact factor.
`
`Collaborator. Bhoj EJ, Li M, Ahrens-Nicklas R, Pyle LC, Wang J, Zhang VW, Clarke C, Wong LJ, Sondheimer N,
`Ficicioglu C, Yudkoff M. (2015). Pathologic variants of the mitochondrial phosphate carrier SLC25A3: Two new patients
`and expansion of the cardiomyopathy/skeletal myopathy phenotype with and without lactic acidosis. JIMD Reports. 19:
`59-66. Impact Factor: No impact factor.
`
`Principal Author. Sondheimer N, Zollo O, Van Deerlin V, Trojanowski JQ. (2014). Analysis of cerebrospinal fluid
`mitochondrial DNA levels in Alzheimer disease. Annals of Neurology. 75(3): 458-60. Impact Factor: 9.977.
`
`Principal Author. Sondheimer N, Soundararajan S, Koutzaki SH, Doyle AM. (2014). Kidney transplantation from a
`deceased donor with metachromatic leukodystrophy. Transplantation. 97(7): e42-4. Impact Factor: 3.828.
`
`Collaborator. Clarke C, Xiao R, Place E, Zhang Z, Sondheimer N, Bennett M, Yudkoff M, Falk MJ. (2013). Mitochondrial
`respiratory chain disease discrimination by retrospective cohort analysis of blood metabolites. Molecular Genetics and
`Metabolism. 110(1-2): 145-52. Impact Factor: 2.625.
`
`Principal Author. Vergano SA, Crossette JM, Cusick FC, Desai BR, Deardorff MA, Sondheimer N. (2013). Improving
`surveillance for hyperammonemia in the newborn. Molecular Genetics and Metabolism. 110(1-2): 102-105. Impact Factor:
`2.625.
`
`Collaborator. Gai X, Ghezzi D, Johnson MA, Biagosch CA, Shamseldin HE, Haack TB, Reyes A, Tsukikawa M, Sheldon
`CA, Srinivasan S, Gorza M, Kremer LS, Wieland T, Strom TM, Polyak E, Place E, Consugar M, Ostrovsky J, Vidoni S,
`Robinson AJ, Wong LJ, Sondheimer N, Salih MA, Al-Jishi E, Raab CP, Bean C, Furlan F, Parini R, Lamperti C, Mayr JA,
`Konstantopoulou V, Huemer M, Pierce EA, Meitinger T, Freisinger P, Sperl W, Prokisch H, Alkuraya FS, Falk MJ, Zeviani
`M. (2013). Mutations in FBXL4, Encoding a Mitochondrial Protein, Cause Early-Onset Mitochondrial Encephalomyopathy.
`American Journal of Human Genetics. 93(3): 482-495. Impact Factor: 10.931.
`
`Principal Author. Sondheimer N. (2013). Newborn screening by sequence and the road ahead. Clinical Chemistry.
`59(7): 1011-3. Impact Factor: 7.911.
`
`Collaborator. Spinale JM, Laskin BL, Sondheimer N, Swartz SJ, Goldstein SL. (2013). High-dose continuous renal
`replacement therapy for neonatal hyperammonemia. Pediatric Nephrology (Berlin, Germany). 28(6): 983-6. Impact Factor:
`2.856.
`
`Principal Author. D'Aco KE, Manno M, Clarke C, Ganesh J, Meyers KE, Sondheimer N. (2013). Mitochondrial
`
`Page 8 of 13
`
`Par Pharmaceutical, Inc. Ex. 1003
`Par v. Horizon, IPR of Patent No. 9,561,197
`Page 9 of 15
`
`

`


`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`

`
`Neal Sondheimer
`
`tRNA(Phe) mutation as a cause of end-stage renal disease in childhood. Pediatric Nephrology (Berlin, Germany).
`28(3): 515-9. Impact Factor: 2.856.
`
`Collaborator. Schadt EE, Banerjee O, Fang G, Feng Z, Wong WH, Zhang X, Kislyuk A, Clark TA, Luong K, Keren-Paz
`A, Chess A, Kumar V, Chen-Plotkin A, Sondheimer N, Korlach J, Kasarskis A. (2013). Modeling kinetic rate variation in
`third generation DNAsequencing data to detect putative modifications to DNA bases. Genome Research. 23(1): 129-41.
`Impact Factor: 14.63.
`
`Principal Author. Grant SF, Glessner JT, Bradfield JP, Zhao J, Tirone JE, Berkowitz RI, Hakonarson H, Sondheimer N.
`(2012). Lack of relationship between mitochondrial heteroplasmy or variation and childhood obesity. International Journal
`of Obesity (London). 36(1): 80-3. Impact Factor: 5.004.
`
`Principal Author. Glatz C, D'Aco K, Smith S, Sondheimer N. (2011). Mutation in the mitochondrial tRNA(Val) causes
`mitochondrial encephalopathy, lactic acidosis and stroke-like episodes. Mitochondrion. 11(4): 615-9. Impact Factor: 3.249.
`
`Principal Author. Falk MJ, Sondheimer N. (2010). Mitochondrial genetic diseases. Current Opinion in Pediatrics. 22(6):
`711-6. Impact Factor: 2.528.
`
`Principal Author. Sondheimer N, Fang JK, Polyak E, Falk MJ, Avadhani NG. (2010). Leucine-rich pentatricopeptide
`repeat containing protein regulates mitochondrial transcription. Biochemistry. 49(35): 7467-73. Impact Factor: 3.015.
`
`Collaborator. Guha M, Tang W, Sondheimer N, Avadhani NG. (2010). Role of Calcineurin, hnRNPA2 and Akt in
`Mitochondrial Respiratory Stress-Mediated Transcription Activation of Nuclear Gene Targets. Biochimica et Biophysica
`Acta. 1797(6-7): 1055-1065. Impact Factor: 4.66.
`
`Principal Author. Chapman KA, Bennett MJ, Sondheimer N. (2008). Increased C3-carnitine in a healthy premature
`infant. Clinical Chemistry. 54(11): 1914-7; discussion 1. Impact Factor: 7.911.
`
`Collaborator. Deardorff MA, Gaddipati Hi, Kaplan P, Sanchez-Lara PA, Sondheimer N, Spinner NB, Hkonarson H,
`Ficicioglu C, Ganesh J, Markello T, Loechelt B, Zand DJ, Yudkoff M, Lichter-Konecki U. (2008). Complex management of a
`patient with a contiguous Xp11.4 gene deletion involving ornithine transcarbamylase: a role for detailed molecular
`analysis in complex presentations of classical diseases. Molecular Genetics & Metabolism. 94(4): 498-502. Impact Factor:
`2.625.
`
`Collaborator. Biswas G, Tang W, Sondheimer N, Guha M, Bansal S, Avadhani NG. (2008). A distinctive physiological
`role for IkappaBbeta in the propagation of mitochondrial respiratory stress signaling. The Journal of Biological Chemistry.
`283(18): 12586-94. Impact Factor: 4.573.
`
`Collaborator. Ernst LM, Sondheimer N, Deardorff MA, Bennett MJ, Pawel BR. (2006). The value of the metabolic
`autopsy in the pediatric hospital setting. The Journal of Pediatrics. 148(6): 779-83. Impact Factor: 3.790.
`
`Collaborator. Liu JJ, Sondheimer N, Lindquist SL. (2002). Changes in the middle region of Sup35 profoundly alter the
`nature of epigenetic inheritance for the yeast prion [PSI+]. Proceedings of the National Academy of Sciences of the
`United States of America. 99 Suppl 4: 16446-53. Impact Factor: 9.674.
`
`Principal Author. Sondheimer N, Lopez N, Craig EA, Lindquist S. (2001). The role of Sis1 in the maintenance of the
`[RNQ +] prion. The EMBO Journal. 20(10): 2435-42. Impact Factor: 10.434.
`
`Principal Author. Lindquist S, Krobitsch S, Li L, Sondheimer N. (2001). Investigating protein conformation-based
`inheritance and disease in yeast. Philosophical Transactions of the Royal Society of London. Series B: Biological
`Sciences. 356(1406):169-76. Impact Factor: 7.055.
`
`Collaborator. Satyal SH, Schmidt E, Kitagawa K , Sondheimer N, Lindquist S, Kramer JM, Morimoto RI. (2000).
`Polyglutamine aggregates alter protein folding homeostasis in Caenorhabditis elegans. Proceedings of the National
`Academy of Sciences of the United States of America. 97(11): 5750-5. Impact Factor: 9.674.
`
`Page 9 of 13
`
`Par Pharmaceutical, Inc. Ex. 1003
`Par v. Horizon, IPR of Patent No. 9,561,197
`Page 10 of 15
`
`

`


`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`

`
`Neal Sondheimer
`
`Collaborator. Sokol RJ , Taylor SF , Devereaux MW , Khandwala R , Sondheimer NJ , Shikes RH , Mierau G. (1996).
`Hepatic oxidant injury and glutathione depletion during total parenteral nutrition in weanling rats. The American journal of
`Physiology. 270(4 Pt 1): G691-700. Impact Factor: 3.077.
`
`Principal Author. Sokol RJ, Devereaux MW, Khandwala RA, Narkewicz MR, Sondheimer NJ. (1990). Effect of vitamin
`E on transport processes in isolated rat hepatocytes. Journal of Pediatric Gastroenterology and Nutrition. 11(2): 261-7.
`Impact Factor: 2.625.
`
`Book Chapters
`DeBerardinis RJ, Sondheimer N, Payan I and Ficicioglu C: Metabolism. In: The Philadelphia Guide: Inpatient Pediatrics.
`Frank G, Shah SS, Catallozzi MC, Zaoutis LB (eds.). Blackwell Publishing, June 2005.
`
`Sondheimer N: Hypoglycemia. In: Comprehensive Pediatric Hospital Medicine. Zaoutis LB & Chiang VW (eds.). Elsevier,
`2007.
`
`4. SUBMITTED PUBLICATIONS
`
`Journal Articles
`
`Principal Author. Mellin-Sanchez, L. and Sondheimer, N. An Infant Refugee with Anemia and Low Serum Vitamin B12.
`Accepted to Clinical Chemistry in 2018.
`
`Co-Author. Veenma, D., Cordeiro, D., Sondheimer, N., Andrews, S. DNAJC12 associated developmental delay,
`movement disorder and mild hyperphenylalaninemia in two brothers: diagnosis by whole exome sequencing re-analysis.
`Submitted to Pediatric Neurology.
`
`Co-Author. Costain, G., et. al. Periodic reanalysis of whole-genome sequencing data enhances the diagnostic advantage
`over standard clinical genetic testing. Submitted to Eur Journal of Hum Genet. (middle author)
`
`Co-Author. Reuter, M. et. al. The Personal Genome Project Canada – findings from the whole-genome sequences of the
`inaugural 56 participants. Accepted at CMAJ. (middle author)
`
`E. Presentations and Special Lectures
`*label invited speaker, keynote speaker or plenary speaker
`
`1. INTERNATIONAL
`
`Abstracts and Other Papers
`
`Invited Lectures and Presentations
`Invited Speaker. Discrete patterns of mitochondrial and nuclear ancestry are associated with the
`April 2017
`risk for preterm birth. Stanford University PRC. Palo Alto, CA. Presenter(s): Sondheimer N.
`(Invited)
`
`Page 10 of 13
`
`Par Pharmaceutical, Inc. Ex. 1003
`Par v. Horizon, IPR of Patent No. 9,561,197
`Page 11 of 15
`
`

`

`Neal Sondheimer
`
`April 2017
`
`March 2016
`
`May 2014
`
`July 2014
`
`June 2013
`
`Oct 2012
`
`Oct 2012
`
`Media Appearances
`May 2013
`Other Presentations
`May 2012
`
`June 2011
`
`Apr 2011
`
`June 2010
`
`May 2010
`
`Nov 2012
`

`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`

`
`Plenary Speaker. Genomic Cooperation and Preterm Birth. March of Dimes Annual Symposium.
`Orlando FL. Presenter(s): Sondheimer, N. (Invited)
`
`Plenary Speaker. Bioenergetics and Genetics. March of Dimes Annual Symposium. Montreal,
`QC. Presenter(s): Sondheimer, N. (Invited)
`
`Invited Speaker. Defects of mitochondrial phosphate transport. Thomas Jefferson
`University, Philadelphia. Pennsylvania, United States. Presenter(s): Sondheimer N. (Invited)
`
`Plenary Speaker. Newborn Screening in the era of genomic medicine. American
`Association of Clinical Chemistry Meetings. Chicago, Illinois, United States. Presenter(s):
`Sondheimer N. (Invited)
`
`Invited Speaker. Regulating the power supply through mitochondrial transcription. Department of
`Biochemistry and Molecular Biology. The Pennsylvania State University, Philadelphia,
`Pennsylvania, United States. Presenter(s): Sondheimer N. (Invited)
`
`Invited Speaker. The somatic stability of MtDNA in aging and disease. Department of
`Epidemiology. Harvard T.H. Chan School of Public Health. Boston, Massachusetts, United
`States. Presenter(s): Sondheimer N. (Invited)
`
`Invited Speaker. Regulation of mitochondrial transcription - Many promoters and more players.
`Department of Pharmacological Sciences, Stony Brook University. Stony Brook, New York,
`United States. Presenter(s): Sondheimer N. (Invited)
`
`Invited Speaker. The Health Show, WAMC Northeast Public Radio (National Public Radio (NPR)
`
`Invited Speaker. The genetics of mitochondrial disease. The Laura Dribin Mitochondrial
`Symposium. Philadelphia, Pennsylvania, United States. Presenter(s): Sondheimer N.
`
`Invited Speaker. Use of the HSP2 promoter in mitochondrial transcription. Genes, Genomes and
`Pediatric Disease Seminar. The Children’s Hospital of Philadelphia. Philadelphia, Pennsylvania,
`United States. Presenter(s): Sondheimer N.
`
`Invited Speaker. Inheritance and Unpredictability: Mitochondrial Heteroplasmy and Its Role in
`Disease. Neonatology Grand Rounds. The Children’s Hospital of Philadelphia. Philadelphia,
`Pennsylvania, United States. Presenter(s): Sondheimer N.
`
`Invited Speaker. Mitochondrial heteroplasmy and the influence of aging. Genes, Genomes and
`Pediatric Disease Retreat Seminar The Children’s Hospital of Philadelphia. Philadelphia,
`Pennsylvania, United States. Presenter(s): Sondheimer N.
`
`Invited Speaker. The influence of aging on mitochondrial heteroplasmy. Center for
`Neurodegenerative Disease Research Lecture Series. Perelman School of Medicine. University
`of Pennsylvania. Philadelphia, Pennsylvania, United States. Presenter(s): Sondheimer N.
`
`Principal Author. Exome Sequencing for Pediatric Disorders. Grand Rounds. The Children's
`Hospital of Philadelphia. Philadelphia, Pennsylvania, Unit

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket